• Polystyrene Microplastics Drive Kidney Toxicity via DDIT4 Pa

  2026-04-25

  This study elucidates how 1 μm polystyrene microplastics (PS-MPs) induce nephrotoxicity through DDIT4-mediated autophagy and apoptosis in human kidney organoids. The findings reveal key molecular mechanisms of microplastic toxicity and underscore the importance of advanced molecular tools for dissecting environmental health hazards.

• Fulvestrant (ICI 182,780): Precision in ER-Positive Cell Ass

  2026-04-24

  This article delivers scenario-driven guidance for biomedical researchers and lab technicians using Fulvestrant (ICI 182,780) (SKU A1428) in cell viability, apoptosis, and resistance studies. Backed by quantitative data and peer-reviewed evidence, it demonstrates how SKU A1428 ensures reproducibility and mechanistic clarity in ER-positive breast cancer workflows.

• OTC-Mediated Ornithine and Astrocyte Glycolysis in Realgar C

  2026-04-24

  This study uncovers how realgar-derived arsenic disrupts the liver–brain metabolic axis, specifically through OTC inhibition and ornithine accumulation, leading to impaired astrocyte glycolysis and CNS toxicity. The mechanistic findings highlight ZBTB7A as a key transcriptional regulator linking hepatic metabolic dysfunction to neuroenergetic deficits and behavioral impairments.

• Zosuquidar (LY335979): Deep Mechanistic and Translational In

  2026-04-23

  Explore Zosuquidar (LY335979) 3HCl as a P-gp inhibitor for multidrug resistance reversal, with unique focus on pharmacokinetic variability, tissue distribution, and practical assay decision-making—delivering depth beyond existing content.

• RESTRICT-seq Reveals KAT6A Dependency in SCC Resistance

  2026-04-23

  The referenced study introduces RESTRICT-seq, a time-gated CRISPR screening approach that dissects epigenetic dependencies in squamous cell carcinoma (SCC) resistance. This work uncovers KAT6A as a key regulator of oncogene-induced senescence and highlights the importance of selective KAT6A inhibition in cancer biology research.

• Meropenem Trihydrate in Antibiotic Resistance & Diagnostics

  2026-04-22

  Meropenem trihydrate stands out as a gold-standard carbapenem antibiotic for probing resistance mechanisms, especially in rapid LC-MS/MS metabolomics workflows. See how this compound enables reproducible, high-impact research in both acute necrotizing pancreatitis models and cutting-edge diagnostics for carbapenemase-producing Enterobacterales.

• FLAG tag Peptide: Precision in Recombinant Protein Detection

  2026-04-22

  The FLAG tag Peptide (DYKDDDDK) streamlines protein purification and detection, empowering researchers with high solubility, enterokinase-cleavage, and reliable affinity resin compatibility. Explore workflow enhancements, troubleshooting strategies, and translational insights—anchored by the latest mechanistic evidence and APExBIO’s rigorous quality.

• Topotecan (SKU B4982): Advanced Strategies for Pediatric Tum

  2026-04-21

  Explore the unique potential of Topotecan in pediatric solid tumor models and apoptosis induction in glioma cells. This in-depth article offers advanced insights and practical guidance for cancer research, highlighting APExBIO’s Topotecan beyond standard assay optimization.

• BMN 673 (Talazoparib): Mechanism, Evidence, and Research Uti

  2026-04-21

  BMN 673 (Talazoparib) is a highly potent, selective PARP1/2 inhibitor that demonstrates superior DNA repair deficiency targeting in cancer research. Its efficacy, molecular mechanism, and protocol parameters are quantitatively defined, supporting reproducibility in homologous recombination deficient cancer models.

• Angiotensin Peptides Enhance SARS-CoV-2 Spike–AXL Binding

  2026-04-20

  This study demonstrates that naturally occurring angiotensin peptides, including Angiotensin (1-7), can enhance the binding of the SARS-CoV-2 spike protein to the AXL receptor. These findings provide new insight into peptide-mediated modulation of viral entry and may inform the design of antiviral and translational research workflows.

• Antimycin A4: Advanced ATP-Citrate Lyase Inhibitor Workflows

  2026-04-20

  Antimycin A4 empowers precision control of mitochondrial energy pathways and lipid biosynthesis in cell-based assays. Its dual inhibition profile enables researchers to dissect metabolic dependencies and troubleshoot complex workflows, setting a new standard for ATP-citrate lyase inhibitor applications.

• Cycloheximide as a Protein Biosynthesis Inhibitor: Workflows

  2026-04-19

  Cycloheximide empowers researchers to dissect protein turnover, apoptosis, and translational control with high temporal precision. This guide translates bench-proven workflows and recent mechanistic advances—including sunitinib resistance in renal cell carcinoma—into actionable protocols for advanced cell biology.

• Homoharringtonine: Cytotoxic Alkaloid for Cancer & SARS-CoV-

  2026-04-18

  Homoharringtonine is a cytotoxic alkaloid that inhibits protein synthesis by targeting the eukaryotic 80S ribosome. It induces cell cycle arrest in leukemic cells and demonstrates potent antiviral activity against SARS-CoV-2, supporting its use in cancer biology and antiviral research. The compound is supplied by APExBIO under SKU N1504.

• CX-5461: Workflow Optimization for RNA Polymerase I Inhibiti

  2026-04-17

  Leverage CX-5461, a potent RNA polymerase I inhibitor, to dissect ribosome biogenesis and overcome chemoresistance in solid tumor research. This guide details experimental workflows, troubleshooting strategies, and advanced use-cases, drawing on the latest mechanistic insights and reference protocols.

• Caspase-4 Colorimetric Assay: Bridging Mechanism and Impact

  2026-04-16

  Explore how precision measurement of caspase-4 activity is reshaping translational research in inflammatory cell death. This thought-leadership article integrates mechanistic insight, strategic assay deployment, and cross-domain perspectives—culminating in a vision for next-generation cell fate modulation.

14771 records 1/985 page Next 12345 下5页 Last page